Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial
Top Cited Papers
Open Access
- 30 January 2014
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 383 (9925), 1297-1304
- https://doi.org/10.1016/s0140-6736(13)62301-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effect of oral immunotherapy to peanut on food-specific quality of lifeAnnals of Allergy, Asthma & Immunology, 2012
- How do peanut and nut-allergic consumers use information on the packaging to avoid allergens?Allergy, 2011
- The multinational birth cohort of EuroPrevall: background, aims and methodsAllergy, 2010
- Quantitative Risk Assessment Relating to Adventitious Presence of Allergens in Food: A Probabilistic Model Applied to Peanut in ChocolateRisk Analysis, 2009
- When is an oral food challenge positive?Allergy, 2009
- Time trends in the prevalence of peanut allergy: three cohorts of children from the same geographical location in the UKAllergy, 2009
- Clinical efficacy and immune regulation with peanut oral immunotherapyJournal of Allergy and Clinical Immunology, 2009
- Development and validation of a self‐administered Food Allergy Quality of Life Questionnaire for childrenClinical and Experimental Allergy, 2009
- Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reactionAllergy, 2007
- Estimation of Relationships for Limited Dependent VariablesEconometrica, 1958